CD8+ CTLs are considered important players in anti-tumor immune responses that recognize tumor antigens and mediate tumor-killing effects via, e.g., pro-inflammatory interferon γ (IFNγ) and cytotoxic granzyme or perforin [4,37]. This evidence concerns the gene PRF1 and neoplasm.